Copper nanoclusters on specific-primer PCR fragments with magnetic capture for the label-free fluorescent sensing of the T315I single nucleotide variant in the - gene

• Published in: Analyst (London) Vol. 147; no. 24; pp. 5732 - 5738
• Main Authors: Lai, Ke-Peng, Su, Yu-Chen, Fu, Bo-Siang, Lin, Kung-Hung, Kou, Hwang-Shang, Wang, Chun-Chi
• Format: Journal Article
• Published: 05.12.2022
• ISSN: 0003-2654; 1364-5528
• DOI: 10.1039/d2an01433e

In this study, a simple and facile procedure using the all or none formation of double-stranded DNA-templated copper nanoclusters on specific-primer PCR fragments was designed to fluorescently identify the T315I single nucleotide variant on the BCR - ABL1 gene. Chronic myeloid leukaemia (CML), a disease caused by the BCR - ABL1 fusion of tyrosine kinase, is well known for the T315I mutation that causes tyrosine kinase inhibitors (TKIs) to be resisted due to the alternative structure of the drug-binding site. Therefore, it is an important single nucleotide variant for clinical detection. In this study, only specific functional primers and the digestion of the wild genotype from the T315I mutation site with specific restriction enzymes were designed, and the different digested products could then be captured using magnetic beads. The final products would allow for fluorescent sensing via the all or none formation of double-stranded DNA-templated copper nanoclusters for the detection of the T315I mutation. This study has been successfully applied for identifying wild and mutant homozygotes and the mutant/wild heterozygote of the T315I mutation. It is expected that this analytical system can serve as a tool for the clinical diagnosis of T315I mutations and be applied to real samples of CML patients in the future. A simple and facile strategy using the all or none formation of dsDNA-templated copper nanoclusters on specific-primer PCR fragments was designed to fluorescently identify the T315I single nucleotide variant on the BCR - ABL1 gene.